nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—CYP2D6—breast cancer	0.139	0.538	CbGaD
Pergolide—CYP3A4—breast cancer	0.119	0.462	CbGaD
Pergolide—HTR2B—Raloxifene—breast cancer	0.0785	0.241	CbGbCtD
Pergolide—CYP3A4—Exemestane—breast cancer	0.0254	0.0781	CbGbCtD
Pergolide—CYP2D6—Idarubicin—breast cancer	0.023	0.0706	CbGbCtD
Pergolide—CYP3A4—Letrozole—breast cancer	0.0216	0.0664	CbGbCtD
Pergolide—CYP3A4—Anastrozole—breast cancer	0.0193	0.0592	CbGbCtD
Pergolide—CYP3A4—Toremifene—breast cancer	0.0176	0.0542	CbGbCtD
Pergolide—CYP3A4—Fulvestrant—breast cancer	0.0164	0.0504	CbGbCtD
Pergolide—CYP3A4—Thiotepa—breast cancer	0.0146	0.0449	CbGbCtD
Pergolide—CYP3A4—Ixabepilone—breast cancer	0.0134	0.041	CbGbCtD
Pergolide—CYP3A4—Lapatinib—breast cancer	0.0129	0.0395	CbGbCtD
Pergolide—CYP2D6—Vinorelbine—breast cancer	0.0112	0.0345	CbGbCtD
Pergolide—CYP2D6—Tamoxifen—breast cancer	0.0101	0.0311	CbGbCtD
Pergolide—CYP3A4—Raloxifene—breast cancer	0.00974	0.0299	CbGbCtD
Pergolide—CYP3A4—Vinorelbine—breast cancer	0.00713	0.0219	CbGbCtD
Pergolide—CYP2D6—Vinblastine—breast cancer	0.00691	0.0212	CbGbCtD
Pergolide—CYP3A4—Tamoxifen—breast cancer	0.00644	0.0198	CbGbCtD
Pergolide—CYP3A4—Mitoxantrone—breast cancer	0.00628	0.0193	CbGbCtD
Pergolide—CYP3A4—Paclitaxel—breast cancer	0.00501	0.0154	CbGbCtD
Pergolide—CYP3A4—Irinotecan—breast cancer	0.00494	0.0152	CbGbCtD
Pergolide—CYP3A4—Vinblastine—breast cancer	0.0044	0.0135	CbGbCtD
Pergolide—CYP2D6—Doxorubicin—breast cancer	0.00425	0.0131	CbGbCtD
Pergolide—CYP3A4—Docetaxel—breast cancer	0.00362	0.0111	CbGbCtD
Pergolide—CYP3A4—Doxorubicin—breast cancer	0.0027	0.0083	CbGbCtD
Pergolide—ADRA1D—epithelium—breast cancer	0.000616	0.0346	CbGeAlD
Pergolide—DRD5—female reproductive system—breast cancer	0.00057	0.032	CbGeAlD
Pergolide—DRD5—female gonad—breast cancer	0.000519	0.0291	CbGeAlD
Pergolide—KCNH2—nipple—breast cancer	0.000507	0.0285	CbGeAlD
Pergolide—ADRA2C—nipple—breast cancer	0.000501	0.0281	CbGeAlD
Pergolide—DRD5—endocrine gland—breast cancer	0.000483	0.0271	CbGeAlD
Pergolide—ADRA1D—female reproductive system—breast cancer	0.000457	0.0257	CbGeAlD
Pergolide—Ergonovine—CYP3A4—breast cancer	0.000429	0.206	CrCbGaD
Pergolide—HTR2B—skin of body—breast cancer	0.000407	0.0229	CbGeAlD
Pergolide—ADRA2A—nipple—breast cancer	0.000399	0.0224	CbGeAlD
Pergolide—ADRA1D—endocrine gland—breast cancer	0.000387	0.0217	CbGeAlD
Pergolide—HTR2B—endometrium—breast cancer	0.000384	0.0216	CbGeAlD
Pergolide—Cabergoline—CYP3A4—breast cancer	0.000375	0.18	CrCbGaD
Pergolide—Methylergometrine—CYP3A4—breast cancer	0.000375	0.18	CrCbGaD
Pergolide—Ergonovine—ABCB1—breast cancer	0.000357	0.172	CrCbGaD
Pergolide—HTR2B—uterus—breast cancer	0.000354	0.0199	CbGeAlD
Pergolide—ADRA1A—epithelium—breast cancer	0.000354	0.0199	CbGeAlD
Pergolide—HTR1B—female reproductive system—breast cancer	0.000353	0.0198	CbGeAlD
Pergolide—HTR2B—adipose tissue—breast cancer	0.000346	0.0194	CbGeAlD
Pergolide—HTR1D—female reproductive system—breast cancer	0.000342	0.0192	CbGeAlD
Pergolide—HTR2C—female reproductive system—breast cancer	0.000339	0.019	CbGeAlD
Pergolide—HTR2B—female reproductive system—breast cancer	0.000318	0.0179	CbGeAlD
Pergolide—HTR2B—adrenal gland—breast cancer	0.00031	0.0174	CbGeAlD
Pergolide—KCNH2—endometrium—breast cancer	0.000306	0.0172	CbGeAlD
Pergolide—ADRA2C—endometrium—breast cancer	0.000302	0.017	CbGeAlD
Pergolide—HTR1B—endocrine gland—breast cancer	0.000299	0.0168	CbGeAlD
Pergolide—Lisuride—CYP2D6—breast cancer	0.000293	0.141	CrCbGaD
Pergolide—ADRA1A—adipose tissue—breast cancer	0.000286	0.016	CbGeAlD
Pergolide—KCNH2—uterus—breast cancer	0.000282	0.0158	CbGeAlD
Pergolide—DRD2—pituitary gland—breast cancer	0.000281	0.0158	CbGeAlD
Pergolide—HTR2A—embryo—breast cancer	0.00028	0.0157	CbGeAlD
Pergolide—ADRA2C—uterus—breast cancer	0.000279	0.0156	CbGeAlD
Pergolide—HTR1A—adrenal gland—breast cancer	0.000278	0.0156	CbGeAlD
Pergolide—KCNH2—pituitary gland—breast cancer	0.000277	0.0156	CbGeAlD
Pergolide—ADRA2C—pituitary gland—breast cancer	0.000273	0.0154	CbGeAlD
Pergolide—ADRA2C—adipose tissue—breast cancer	0.000272	0.0153	CbGeAlD
Pergolide—ADRA1A—adrenal gland—breast cancer	0.000256	0.0144	CbGeAlD
Pergolide—KCNH2—female reproductive system—breast cancer	0.000254	0.0142	CbGeAlD
Pergolide—Lisuride—CYP3A4—breast cancer	0.000251	0.121	CrCbGaD
Pergolide—KCNH2—adrenal gland—breast cancer	0.000248	0.0139	CbGeAlD
Pergolide—ADRA2C—adrenal gland—breast cancer	0.000244	0.0137	CbGeAlD
Pergolide—HTR1A—endocrine gland—breast cancer	0.000241	0.0135	CbGeAlD
Pergolide—ADRA2A—endometrium—breast cancer	0.000241	0.0135	CbGeAlD
Pergolide—KCNH2—bone marrow—breast cancer	0.00024	0.0135	CbGeAlD
Pergolide—KCNH2—female gonad—breast cancer	0.000231	0.013	CbGeAlD
Pergolide—HTR2A—epithelium—breast cancer	0.000229	0.0128	CbGeAlD
Pergolide—ADRA2C—female gonad—breast cancer	0.000228	0.0128	CbGeAlD
Pergolide—ADRA1A—endocrine gland—breast cancer	0.000222	0.0125	CbGeAlD
Pergolide—ADRA2A—uterus—breast cancer	0.000222	0.0125	CbGeAlD
Pergolide—ADRA2A—pituitary gland—breast cancer	0.000218	0.0123	CbGeAlD
Pergolide—DRD2—endocrine gland—breast cancer	0.000218	0.0122	CbGeAlD
Pergolide—ADRA2A—adipose tissue—breast cancer	0.000217	0.0122	CbGeAlD
Pergolide—KCNH2—endocrine gland—breast cancer	0.000215	0.0121	CbGeAlD
Pergolide—ADRA2A—female reproductive system—breast cancer	0.0002	0.0112	CbGeAlD
Pergolide—ADRA2A—adrenal gland—breast cancer	0.000195	0.0109	CbGeAlD
Pergolide—HTR2B—lymph node—breast cancer	0.000186	0.0104	CbGeAlD
Pergolide—HTR2A—pituitary gland—breast cancer	0.000186	0.0104	CbGeAlD
Pergolide—ADRA2A—female gonad—breast cancer	0.000182	0.0102	CbGeAlD
Pergolide—HTR2A—female reproductive system—breast cancer	0.00017	0.00954	CbGeAlD
Pergolide—ADRA2A—endocrine gland—breast cancer	0.000169	0.00949	CbGeAlD
Pergolide—HTR2A—adrenal gland—breast cancer	0.000166	0.00931	CbGeAlD
Pergolide—CYP3A4—female reproductive system—breast cancer	0.000157	0.00883	CbGeAlD
Pergolide—CYP2D6—female reproductive system—breast cancer	0.000155	0.00869	CbGeAlD
Pergolide—KCNH2—lymph node—breast cancer	0.000148	0.00833	CbGeAlD
Pergolide—ADRA2C—lymph node—breast cancer	0.000146	0.00822	CbGeAlD
Pergolide—HTR2A—endocrine gland—breast cancer	0.000144	0.00807	CbGeAlD
Pergolide—CYP2D6—female gonad—breast cancer	0.000141	0.00791	CbGeAlD
Pergolide—CYP3A4—endocrine gland—breast cancer	0.000133	0.00747	CbGeAlD
Pergolide—CYP2D6—endocrine gland—breast cancer	0.000131	0.00735	CbGeAlD
Pergolide—ADRA2A—lymph node—breast cancer	0.000117	0.00656	CbGeAlD
Pergolide—Hyperhidrosis—Capecitabine—breast cancer	3.62e-05	0.00013	CcSEcCtD
Pergolide—Oedema peripheral—Epirubicin—breast cancer	3.62e-05	0.000129	CcSEcCtD
Pergolide—Hypotension—Docetaxel—breast cancer	3.62e-05	0.000129	CcSEcCtD
Pergolide—Haematuria—Doxorubicin—breast cancer	3.61e-05	0.000129	CcSEcCtD
Pergolide—Body temperature increased—Paclitaxel—breast cancer	3.61e-05	0.000129	CcSEcCtD
Pergolide—Abdominal pain—Paclitaxel—breast cancer	3.61e-05	0.000129	CcSEcCtD
Pergolide—Epistaxis—Doxorubicin—breast cancer	3.57e-05	0.000128	CcSEcCtD
Pergolide—Anorexia—Capecitabine—breast cancer	3.57e-05	0.000128	CcSEcCtD
Pergolide—Vomiting—Mitoxantrone—breast cancer	3.56e-05	0.000127	CcSEcCtD
Pergolide—Vomiting—Irinotecan—breast cancer	3.56e-05	0.000127	CcSEcCtD
Pergolide—Sinusitis—Doxorubicin—breast cancer	3.56e-05	0.000127	CcSEcCtD
Pergolide—Dizziness—Fluorouracil—breast cancer	3.55e-05	0.000127	CcSEcCtD
Pergolide—Visual impairment—Epirubicin—breast cancer	3.54e-05	0.000127	CcSEcCtD
Pergolide—Rash—Mitoxantrone—breast cancer	3.53e-05	0.000126	CcSEcCtD
Pergolide—Rash—Irinotecan—breast cancer	3.53e-05	0.000126	CcSEcCtD
Pergolide—Dermatitis—Mitoxantrone—breast cancer	3.53e-05	0.000126	CcSEcCtD
Pergolide—Dermatitis—Irinotecan—breast cancer	3.53e-05	0.000126	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Docetaxel—breast cancer	3.53e-05	0.000126	CcSEcCtD
Pergolide—Chills—Methotrexate—breast cancer	3.53e-05	0.000126	CcSEcCtD
Pergolide—Headache—Mitoxantrone—breast cancer	3.51e-05	0.000125	CcSEcCtD
Pergolide—Headache—Irinotecan—breast cancer	3.51e-05	0.000125	CcSEcCtD
Pergolide—Hypotension—Capecitabine—breast cancer	3.5e-05	0.000125	CcSEcCtD
Pergolide—Insomnia—Docetaxel—breast cancer	3.5e-05	0.000125	CcSEcCtD
Pergolide—Paraesthesia—Docetaxel—breast cancer	3.48e-05	0.000124	CcSEcCtD
Pergolide—Alopecia—Methotrexate—breast cancer	3.47e-05	0.000124	CcSEcCtD
Pergolide—Vomiting—Gemcitabine—breast cancer	3.47e-05	0.000124	CcSEcCtD
Pergolide—Bradycardia—Doxorubicin—breast cancer	3.46e-05	0.000124	CcSEcCtD
Pergolide—Dyspnoea—Docetaxel—breast cancer	3.45e-05	0.000123	CcSEcCtD
Pergolide—Somnolence—Docetaxel—breast cancer	3.44e-05	0.000123	CcSEcCtD
Pergolide—Rash—Gemcitabine—breast cancer	3.44e-05	0.000123	CcSEcCtD
Pergolide—Dermatitis—Gemcitabine—breast cancer	3.44e-05	0.000123	CcSEcCtD
Pergolide—Eye disorder—Epirubicin—breast cancer	3.44e-05	0.000123	CcSEcCtD
Pergolide—Tinnitus—Epirubicin—breast cancer	3.43e-05	0.000123	CcSEcCtD
Pergolide—Headache—Gemcitabine—breast cancer	3.42e-05	0.000122	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Capecitabine—breast cancer	3.42e-05	0.000122	CcSEcCtD
Pergolide—Vomiting—Fluorouracil—breast cancer	3.41e-05	0.000122	CcSEcCtD
Pergolide—Rhinitis—Doxorubicin—breast cancer	3.41e-05	0.000122	CcSEcCtD
Pergolide—Dyspepsia—Docetaxel—breast cancer	3.41e-05	0.000122	CcSEcCtD
Pergolide—Hepatitis—Doxorubicin—breast cancer	3.4e-05	0.000122	CcSEcCtD
Pergolide—Insomnia—Capecitabine—breast cancer	3.39e-05	0.000121	CcSEcCtD
Pergolide—Rash—Fluorouracil—breast cancer	3.38e-05	0.000121	CcSEcCtD
Pergolide—Dermatitis—Fluorouracil—breast cancer	3.38e-05	0.000121	CcSEcCtD
Pergolide—Pharyngitis—Doxorubicin—breast cancer	3.38e-05	0.000121	CcSEcCtD
Pergolide—Paraesthesia—Capecitabine—breast cancer	3.37e-05	0.00012	CcSEcCtD
Pergolide—Decreased appetite—Docetaxel—breast cancer	3.37e-05	0.00012	CcSEcCtD
Pergolide—Headache—Fluorouracil—breast cancer	3.36e-05	0.00012	CcSEcCtD
Pergolide—Oedema peripheral—Doxorubicin—breast cancer	3.35e-05	0.00012	CcSEcCtD
Pergolide—Dysgeusia—Methotrexate—breast cancer	3.35e-05	0.00012	CcSEcCtD
Pergolide—Dyspnoea—Capecitabine—breast cancer	3.34e-05	0.000119	CcSEcCtD
Pergolide—Nausea—Mitoxantrone—breast cancer	3.33e-05	0.000119	CcSEcCtD
Pergolide—Nausea—Irinotecan—breast cancer	3.33e-05	0.000119	CcSEcCtD
Pergolide—Pain—Docetaxel—breast cancer	3.31e-05	0.000118	CcSEcCtD
Pergolide—Constipation—Docetaxel—breast cancer	3.31e-05	0.000118	CcSEcCtD
Pergolide—Back pain—Methotrexate—breast cancer	3.31e-05	0.000118	CcSEcCtD
Pergolide—Dyspepsia—Capecitabine—breast cancer	3.3e-05	0.000118	CcSEcCtD
Pergolide—Chills—Epirubicin—breast cancer	3.3e-05	0.000118	CcSEcCtD
Pergolide—Arrhythmia—Epirubicin—breast cancer	3.28e-05	0.000117	CcSEcCtD
Pergolide—Visual impairment—Doxorubicin—breast cancer	3.28e-05	0.000117	CcSEcCtD
Pergolide—Asthenia—Paclitaxel—breast cancer	3.28e-05	0.000117	CcSEcCtD
Pergolide—Decreased appetite—Capecitabine—breast cancer	3.26e-05	0.000116	CcSEcCtD
Pergolide—Alopecia—Epirubicin—breast cancer	3.25e-05	0.000116	CcSEcCtD
Pergolide—Nausea—Gemcitabine—breast cancer	3.24e-05	0.000116	CcSEcCtD
Pergolide—Pruritus—Paclitaxel—breast cancer	3.23e-05	0.000116	CcSEcCtD
Pergolide—Pain—Capecitabine—breast cancer	3.21e-05	0.000115	CcSEcCtD
Pergolide—Constipation—Capecitabine—breast cancer	3.21e-05	0.000115	CcSEcCtD
Pergolide—Feeling abnormal—Docetaxel—breast cancer	3.19e-05	0.000114	CcSEcCtD
Pergolide—Nausea—Fluorouracil—breast cancer	3.19e-05	0.000114	CcSEcCtD
Pergolide—Eye disorder—Doxorubicin—breast cancer	3.18e-05	0.000114	CcSEcCtD
Pergolide—Ill-defined disorder—Methotrexate—breast cancer	3.17e-05	0.000113	CcSEcCtD
Pergolide—Tinnitus—Doxorubicin—breast cancer	3.17e-05	0.000113	CcSEcCtD
Pergolide—Gastrointestinal pain—Docetaxel—breast cancer	3.17e-05	0.000113	CcSEcCtD
Pergolide—Anaemia—Methotrexate—breast cancer	3.16e-05	0.000113	CcSEcCtD
Pergolide—Flatulence—Epirubicin—breast cancer	3.15e-05	0.000113	CcSEcCtD
Pergolide—Tension—Epirubicin—breast cancer	3.14e-05	0.000112	CcSEcCtD
Pergolide—Dysgeusia—Epirubicin—breast cancer	3.13e-05	0.000112	CcSEcCtD
Pergolide—Diarrhoea—Paclitaxel—breast cancer	3.13e-05	0.000112	CcSEcCtD
Pergolide—Nervousness—Epirubicin—breast cancer	3.11e-05	0.000111	CcSEcCtD
Pergolide—Back pain—Epirubicin—breast cancer	3.1e-05	0.000111	CcSEcCtD
Pergolide—Feeling abnormal—Capecitabine—breast cancer	3.09e-05	0.00011	CcSEcCtD
Pergolide—Malaise—Methotrexate—breast cancer	3.08e-05	0.00011	CcSEcCtD
Pergolide—Vertigo—Methotrexate—breast cancer	3.07e-05	0.00011	CcSEcCtD
Pergolide—Gastrointestinal pain—Capecitabine—breast cancer	3.07e-05	0.00011	CcSEcCtD
Pergolide—Abdominal pain—Docetaxel—breast cancer	3.06e-05	0.000109	CcSEcCtD
Pergolide—Body temperature increased—Docetaxel—breast cancer	3.06e-05	0.000109	CcSEcCtD
Pergolide—Leukopenia—Methotrexate—breast cancer	3.06e-05	0.000109	CcSEcCtD
Pergolide—Chills—Doxorubicin—breast cancer	3.05e-05	0.000109	CcSEcCtD
Pergolide—Arrhythmia—Doxorubicin—breast cancer	3.04e-05	0.000109	CcSEcCtD
Pergolide—Dizziness—Paclitaxel—breast cancer	3.02e-05	0.000108	CcSEcCtD
Pergolide—Alopecia—Doxorubicin—breast cancer	3.01e-05	0.000107	CcSEcCtD
Pergolide—Cough—Methotrexate—breast cancer	2.98e-05	0.000107	CcSEcCtD
Pergolide—Ill-defined disorder—Epirubicin—breast cancer	2.97e-05	0.000106	CcSEcCtD
Pergolide—Body temperature increased—Capecitabine—breast cancer	2.96e-05	0.000106	CcSEcCtD
Pergolide—Abdominal pain—Capecitabine—breast cancer	2.96e-05	0.000106	CcSEcCtD
Pergolide—Convulsion—Methotrexate—breast cancer	2.96e-05	0.000106	CcSEcCtD
Pergolide—Anaemia—Epirubicin—breast cancer	2.96e-05	0.000106	CcSEcCtD
Pergolide—Agitation—Epirubicin—breast cancer	2.94e-05	0.000105	CcSEcCtD
Pergolide—Flatulence—Doxorubicin—breast cancer	2.92e-05	0.000104	CcSEcCtD
Pergolide—Chest pain—Methotrexate—breast cancer	2.91e-05	0.000104	CcSEcCtD
Pergolide—Myalgia—Methotrexate—breast cancer	2.91e-05	0.000104	CcSEcCtD
Pergolide—Arthralgia—Methotrexate—breast cancer	2.91e-05	0.000104	CcSEcCtD
Pergolide—Tension—Doxorubicin—breast cancer	2.91e-05	0.000104	CcSEcCtD
Pergolide—Vomiting—Paclitaxel—breast cancer	2.9e-05	0.000104	CcSEcCtD
Pergolide—Dysgeusia—Doxorubicin—breast cancer	2.9e-05	0.000104	CcSEcCtD
Pergolide—Malaise—Epirubicin—breast cancer	2.89e-05	0.000103	CcSEcCtD
Pergolide—Rash—Paclitaxel—breast cancer	2.88e-05	0.000103	CcSEcCtD
Pergolide—Dermatitis—Paclitaxel—breast cancer	2.88e-05	0.000103	CcSEcCtD
Pergolide—Discomfort—Methotrexate—breast cancer	2.88e-05	0.000103	CcSEcCtD
Pergolide—Nervousness—Doxorubicin—breast cancer	2.88e-05	0.000103	CcSEcCtD
Pergolide—Vertigo—Epirubicin—breast cancer	2.88e-05	0.000103	CcSEcCtD
Pergolide—Syncope—Epirubicin—breast cancer	2.87e-05	0.000103	CcSEcCtD
Pergolide—Leukopenia—Epirubicin—breast cancer	2.86e-05	0.000102	CcSEcCtD
Pergolide—Back pain—Doxorubicin—breast cancer	2.86e-05	0.000102	CcSEcCtD
Pergolide—Headache—Paclitaxel—breast cancer	2.86e-05	0.000102	CcSEcCtD
Pergolide—Palpitations—Epirubicin—breast cancer	2.83e-05	0.000101	CcSEcCtD
Pergolide—Confusional state—Methotrexate—breast cancer	2.81e-05	0.000101	CcSEcCtD
Pergolide—Loss of consciousness—Epirubicin—breast cancer	2.81e-05	0.000101	CcSEcCtD
Pergolide—Cough—Epirubicin—breast cancer	2.79e-05	9.98e-05	CcSEcCtD
Pergolide—Asthenia—Docetaxel—breast cancer	2.78e-05	9.93e-05	CcSEcCtD
Pergolide—Convulsion—Epirubicin—breast cancer	2.77e-05	9.91e-05	CcSEcCtD
Pergolide—Infection—Methotrexate—breast cancer	2.77e-05	9.91e-05	CcSEcCtD
Pergolide—Hypertension—Epirubicin—breast cancer	2.76e-05	9.88e-05	CcSEcCtD
Pergolide—Ill-defined disorder—Doxorubicin—breast cancer	2.75e-05	9.82e-05	CcSEcCtD
Pergolide—Pruritus—Docetaxel—breast cancer	2.74e-05	9.79e-05	CcSEcCtD
Pergolide—Anaemia—Doxorubicin—breast cancer	2.74e-05	9.78e-05	CcSEcCtD
Pergolide—Thrombocytopenia—Methotrexate—breast cancer	2.73e-05	9.77e-05	CcSEcCtD
Pergolide—Arthralgia—Epirubicin—breast cancer	2.72e-05	9.74e-05	CcSEcCtD
Pergolide—Chest pain—Epirubicin—breast cancer	2.72e-05	9.74e-05	CcSEcCtD
Pergolide—Myalgia—Epirubicin—breast cancer	2.72e-05	9.74e-05	CcSEcCtD
Pergolide—Agitation—Doxorubicin—breast cancer	2.72e-05	9.73e-05	CcSEcCtD
Pergolide—Anxiety—Epirubicin—breast cancer	2.72e-05	9.7e-05	CcSEcCtD
Pergolide—Nausea—Paclitaxel—breast cancer	2.71e-05	9.7e-05	CcSEcCtD
Pergolide—Hyperhidrosis—Methotrexate—breast cancer	2.7e-05	9.64e-05	CcSEcCtD
Pergolide—Discomfort—Epirubicin—breast cancer	2.69e-05	9.62e-05	CcSEcCtD
Pergolide—Asthenia—Capecitabine—breast cancer	2.69e-05	9.61e-05	CcSEcCtD
Pergolide—Malaise—Doxorubicin—breast cancer	2.67e-05	9.54e-05	CcSEcCtD
Pergolide—Dry mouth—Epirubicin—breast cancer	2.66e-05	9.52e-05	CcSEcCtD
Pergolide—Vertigo—Doxorubicin—breast cancer	2.66e-05	9.51e-05	CcSEcCtD
Pergolide—Anorexia—Methotrexate—breast cancer	2.66e-05	9.51e-05	CcSEcCtD
Pergolide—Syncope—Doxorubicin—breast cancer	2.66e-05	9.49e-05	CcSEcCtD
Pergolide—Pruritus—Capecitabine—breast cancer	2.65e-05	9.48e-05	CcSEcCtD
Pergolide—Leukopenia—Doxorubicin—breast cancer	2.65e-05	9.47e-05	CcSEcCtD
Pergolide—Diarrhoea—Docetaxel—breast cancer	2.65e-05	9.47e-05	CcSEcCtD
Pergolide—Confusional state—Epirubicin—breast cancer	2.63e-05	9.41e-05	CcSEcCtD
Pergolide—Palpitations—Doxorubicin—breast cancer	2.62e-05	9.35e-05	CcSEcCtD
Pergolide—Oedema—Epirubicin—breast cancer	2.61e-05	9.34e-05	CcSEcCtD
Pergolide—Hypotension—Methotrexate—breast cancer	2.61e-05	9.32e-05	CcSEcCtD
Pergolide—Loss of consciousness—Doxorubicin—breast cancer	2.6e-05	9.3e-05	CcSEcCtD
Pergolide—Infection—Epirubicin—breast cancer	2.59e-05	9.27e-05	CcSEcCtD
Pergolide—Cough—Doxorubicin—breast cancer	2.58e-05	9.24e-05	CcSEcCtD
Pergolide—Shock—Epirubicin—breast cancer	2.57e-05	9.18e-05	CcSEcCtD
Pergolide—Convulsion—Doxorubicin—breast cancer	2.57e-05	9.17e-05	CcSEcCtD
Pergolide—Diarrhoea—Capecitabine—breast cancer	2.57e-05	9.17e-05	CcSEcCtD
Pergolide—Dizziness—Docetaxel—breast cancer	2.56e-05	9.15e-05	CcSEcCtD
Pergolide—Thrombocytopenia—Epirubicin—breast cancer	2.56e-05	9.14e-05	CcSEcCtD
Pergolide—Hypertension—Doxorubicin—breast cancer	2.56e-05	9.14e-05	CcSEcCtD
Pergolide—Tachycardia—Epirubicin—breast cancer	2.55e-05	9.11e-05	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.54e-05	9.09e-05	CcSEcCtD
Pergolide—Hyperhidrosis—Epirubicin—breast cancer	2.53e-05	9.02e-05	CcSEcCtD
Pergolide—Insomnia—Methotrexate—breast cancer	2.52e-05	9.02e-05	CcSEcCtD
Pergolide—Myalgia—Doxorubicin—breast cancer	2.52e-05	9.01e-05	CcSEcCtD
Pergolide—Chest pain—Doxorubicin—breast cancer	2.52e-05	9.01e-05	CcSEcCtD
Pergolide—Arthralgia—Doxorubicin—breast cancer	2.52e-05	9.01e-05	CcSEcCtD
Pergolide—Anxiety—Doxorubicin—breast cancer	2.51e-05	8.98e-05	CcSEcCtD
Pergolide—Paraesthesia—Methotrexate—breast cancer	2.51e-05	8.96e-05	CcSEcCtD
Pergolide—Discomfort—Doxorubicin—breast cancer	2.49e-05	8.9e-05	CcSEcCtD
Pergolide—Anorexia—Epirubicin—breast cancer	2.49e-05	8.9e-05	CcSEcCtD
Pergolide—Dyspnoea—Methotrexate—breast cancer	2.49e-05	8.89e-05	CcSEcCtD
Pergolide—Somnolence—Methotrexate—breast cancer	2.48e-05	8.87e-05	CcSEcCtD
Pergolide—Dizziness—Capecitabine—breast cancer	2.48e-05	8.86e-05	CcSEcCtD
Pergolide—Dry mouth—Doxorubicin—breast cancer	2.47e-05	8.81e-05	CcSEcCtD
Pergolide—Vomiting—Docetaxel—breast cancer	2.46e-05	8.8e-05	CcSEcCtD
Pergolide—Dyspepsia—Methotrexate—breast cancer	2.46e-05	8.78e-05	CcSEcCtD
Pergolide—Rash—Docetaxel—breast cancer	2.44e-05	8.73e-05	CcSEcCtD
Pergolide—Hypotension—Epirubicin—breast cancer	2.44e-05	8.72e-05	CcSEcCtD
Pergolide—Dermatitis—Docetaxel—breast cancer	2.44e-05	8.72e-05	CcSEcCtD
Pergolide—Confusional state—Doxorubicin—breast cancer	2.44e-05	8.71e-05	CcSEcCtD
Pergolide—Decreased appetite—Methotrexate—breast cancer	2.43e-05	8.67e-05	CcSEcCtD
Pergolide—Headache—Docetaxel—breast cancer	2.43e-05	8.67e-05	CcSEcCtD
Pergolide—Oedema—Doxorubicin—breast cancer	2.42e-05	8.64e-05	CcSEcCtD
Pergolide—Infection—Doxorubicin—breast cancer	2.4e-05	8.58e-05	CcSEcCtD
Pergolide—Pain—Methotrexate—breast cancer	2.39e-05	8.53e-05	CcSEcCtD
Pergolide—Vomiting—Capecitabine—breast cancer	2.38e-05	8.52e-05	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.38e-05	8.51e-05	CcSEcCtD
Pergolide—Shock—Doxorubicin—breast cancer	2.38e-05	8.5e-05	CcSEcCtD
Pergolide—Thrombocytopenia—Doxorubicin—breast cancer	2.37e-05	8.46e-05	CcSEcCtD
Pergolide—Rash—Capecitabine—breast cancer	2.36e-05	8.45e-05	CcSEcCtD
Pergolide—Insomnia—Epirubicin—breast cancer	2.36e-05	8.44e-05	CcSEcCtD
Pergolide—Dermatitis—Capecitabine—breast cancer	2.36e-05	8.44e-05	CcSEcCtD
Pergolide—Tachycardia—Doxorubicin—breast cancer	2.36e-05	8.43e-05	CcSEcCtD
Pergolide—Headache—Capecitabine—breast cancer	2.35e-05	8.39e-05	CcSEcCtD
Pergolide—Paraesthesia—Epirubicin—breast cancer	2.35e-05	8.38e-05	CcSEcCtD
Pergolide—Hyperhidrosis—Doxorubicin—breast cancer	2.34e-05	8.35e-05	CcSEcCtD
Pergolide—Dyspnoea—Epirubicin—breast cancer	2.33e-05	8.32e-05	CcSEcCtD
Pergolide—Somnolence—Epirubicin—breast cancer	2.32e-05	8.3e-05	CcSEcCtD
Pergolide—Anorexia—Doxorubicin—breast cancer	2.3e-05	8.23e-05	CcSEcCtD
Pergolide—Nausea—Docetaxel—breast cancer	2.3e-05	8.22e-05	CcSEcCtD
Pergolide—Feeling abnormal—Methotrexate—breast cancer	2.3e-05	8.22e-05	CcSEcCtD
Pergolide—Dyspepsia—Epirubicin—breast cancer	2.3e-05	8.22e-05	CcSEcCtD
Pergolide—Gastrointestinal pain—Methotrexate—breast cancer	2.28e-05	8.16e-05	CcSEcCtD
Pergolide—Decreased appetite—Epirubicin—breast cancer	2.27e-05	8.12e-05	CcSEcCtD
Pergolide—Hypotension—Doxorubicin—breast cancer	2.26e-05	8.07e-05	CcSEcCtD
Pergolide—Constipation—Epirubicin—breast cancer	2.23e-05	7.98e-05	CcSEcCtD
Pergolide—Pain—Epirubicin—breast cancer	2.23e-05	7.98e-05	CcSEcCtD
Pergolide—Nausea—Capecitabine—breast cancer	2.23e-05	7.96e-05	CcSEcCtD
Pergolide—Abdominal pain—Methotrexate—breast cancer	2.21e-05	7.89e-05	CcSEcCtD
Pergolide—Body temperature increased—Methotrexate—breast cancer	2.21e-05	7.89e-05	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.2e-05	7.87e-05	CcSEcCtD
Pergolide—Insomnia—Doxorubicin—breast cancer	2.19e-05	7.81e-05	CcSEcCtD
Pergolide—Paraesthesia—Doxorubicin—breast cancer	2.17e-05	7.76e-05	CcSEcCtD
Pergolide—Dyspnoea—Doxorubicin—breast cancer	2.15e-05	7.7e-05	CcSEcCtD
Pergolide—Feeling abnormal—Epirubicin—breast cancer	2.15e-05	7.69e-05	CcSEcCtD
Pergolide—Somnolence—Doxorubicin—breast cancer	2.15e-05	7.68e-05	CcSEcCtD
Pergolide—Gastrointestinal pain—Epirubicin—breast cancer	2.14e-05	7.63e-05	CcSEcCtD
Pergolide—Dyspepsia—Doxorubicin—breast cancer	2.13e-05	7.6e-05	CcSEcCtD
Pergolide—Decreased appetite—Doxorubicin—breast cancer	2.1e-05	7.51e-05	CcSEcCtD
Pergolide—Constipation—Doxorubicin—breast cancer	2.07e-05	7.39e-05	CcSEcCtD
Pergolide—Pain—Doxorubicin—breast cancer	2.07e-05	7.39e-05	CcSEcCtD
Pergolide—Abdominal pain—Epirubicin—breast cancer	2.06e-05	7.38e-05	CcSEcCtD
Pergolide—Body temperature increased—Epirubicin—breast cancer	2.06e-05	7.38e-05	CcSEcCtD
Pergolide—Asthenia—Methotrexate—breast cancer	2e-05	7.16e-05	CcSEcCtD
Pergolide—Feeling abnormal—Doxorubicin—breast cancer	1.99e-05	7.12e-05	CcSEcCtD
Pergolide—Gastrointestinal pain—Doxorubicin—breast cancer	1.98e-05	7.06e-05	CcSEcCtD
Pergolide—Pruritus—Methotrexate—breast cancer	1.97e-05	7.06e-05	CcSEcCtD
Pergolide—Body temperature increased—Doxorubicin—breast cancer	1.91e-05	6.83e-05	CcSEcCtD
Pergolide—Abdominal pain—Doxorubicin—breast cancer	1.91e-05	6.83e-05	CcSEcCtD
Pergolide—Diarrhoea—Methotrexate—breast cancer	1.91e-05	6.83e-05	CcSEcCtD
Pergolide—Asthenia—Epirubicin—breast cancer	1.87e-05	6.7e-05	CcSEcCtD
Pergolide—Pruritus—Epirubicin—breast cancer	1.85e-05	6.6e-05	CcSEcCtD
Pergolide—Dizziness—Methotrexate—breast cancer	1.85e-05	6.6e-05	CcSEcCtD
Pergolide—Diarrhoea—Epirubicin—breast cancer	1.79e-05	6.39e-05	CcSEcCtD
Pergolide—Vomiting—Methotrexate—breast cancer	1.77e-05	6.34e-05	CcSEcCtD
Pergolide—Rash—Methotrexate—breast cancer	1.76e-05	6.29e-05	CcSEcCtD
Pergolide—Dermatitis—Methotrexate—breast cancer	1.76e-05	6.28e-05	CcSEcCtD
Pergolide—Headache—Methotrexate—breast cancer	1.75e-05	6.25e-05	CcSEcCtD
Pergolide—Asthenia—Doxorubicin—breast cancer	1.73e-05	6.2e-05	CcSEcCtD
Pergolide—Dizziness—Epirubicin—breast cancer	1.73e-05	6.17e-05	CcSEcCtD
Pergolide—Pruritus—Doxorubicin—breast cancer	1.71e-05	6.11e-05	CcSEcCtD
Pergolide—Vomiting—Epirubicin—breast cancer	1.66e-05	5.94e-05	CcSEcCtD
Pergolide—Nausea—Methotrexate—breast cancer	1.66e-05	5.93e-05	CcSEcCtD
Pergolide—Diarrhoea—Doxorubicin—breast cancer	1.65e-05	5.91e-05	CcSEcCtD
Pergolide—Rash—Epirubicin—breast cancer	1.65e-05	5.89e-05	CcSEcCtD
Pergolide—Dermatitis—Epirubicin—breast cancer	1.65e-05	5.88e-05	CcSEcCtD
Pergolide—Headache—Epirubicin—breast cancer	1.64e-05	5.85e-05	CcSEcCtD
Pergolide—Dizziness—Doxorubicin—breast cancer	1.6e-05	5.71e-05	CcSEcCtD
Pergolide—Nausea—Epirubicin—breast cancer	1.55e-05	5.55e-05	CcSEcCtD
Pergolide—Vomiting—Doxorubicin—breast cancer	1.54e-05	5.49e-05	CcSEcCtD
Pergolide—Rash—Doxorubicin—breast cancer	1.52e-05	5.45e-05	CcSEcCtD
Pergolide—Dermatitis—Doxorubicin—breast cancer	1.52e-05	5.44e-05	CcSEcCtD
Pergolide—Headache—Doxorubicin—breast cancer	1.51e-05	5.41e-05	CcSEcCtD
Pergolide—Nausea—Doxorubicin—breast cancer	1.44e-05	5.13e-05	CcSEcCtD
Pergolide—ADRA2A—Signaling Pathways—MDM2—breast cancer	2.21e-06	1.88e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—HRAS—breast cancer	2.21e-06	1.88e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CASP3—breast cancer	2.21e-06	1.88e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL2—breast cancer	2.21e-06	1.88e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EGFR—breast cancer	2.2e-06	1.88e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EGFR—breast cancer	2.2e-06	1.88e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK8—breast cancer	2.2e-06	1.87e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RAF1—breast cancer	2.2e-06	1.87e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AKT1—breast cancer	2.2e-06	1.87e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—breast cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AKT1—breast cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RELA—breast cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SRC—breast cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—STAT3—breast cancer	2.19e-06	1.86e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PIK3CA—breast cancer	2.19e-06	1.86e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CG—breast cancer	2.19e-06	1.86e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SRC—breast cancer	2.18e-06	1.86e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ERBB2—breast cancer	2.18e-06	1.85e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CASP3—breast cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL2—breast cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—breast cancer	2.16e-06	1.84e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—breast cancer	2.16e-06	1.84e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PIK3CA—breast cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCND1—breast cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MTOR—breast cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—JUN—breast cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.13e-06	1.82e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.13e-06	1.81e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CASP3—breast cancer	2.13e-06	1.81e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL2—breast cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—breast cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SRC—breast cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—breast cancer	2.12e-06	1.8e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCND1—breast cancer	2.12e-06	1.8e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—breast cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—STAT3—breast cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—JUN—breast cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—KRAS—breast cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—COMT—breast cancer	2.1e-06	1.79e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—STAT3—breast cancer	2.1e-06	1.79e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTP1—breast cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK3—breast cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SRC—breast cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—breast cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—breast cancer	2.08e-06	1.77e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—KRAS—breast cancer	2.08e-06	1.77e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—KRAS—breast cancer	2.08e-06	1.77e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.08e-06	1.77e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PTEN—breast cancer	2.08e-06	1.77e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.07e-06	1.76e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—HRAS—breast cancer	2.07e-06	1.76e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—JUN—breast cancer	2.07e-06	1.76e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMOX1—breast cancer	2.07e-06	1.76e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.07e-06	1.76e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—breast cancer	2.07e-06	1.76e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ITPR1—breast cancer	2.06e-06	1.75e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PIK3CA—breast cancer	2.06e-06	1.75e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—breast cancer	2.05e-06	1.75e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.05e-06	1.75e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.05e-06	1.75e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.05e-06	1.74e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—STAT3—breast cancer	2.05e-06	1.74e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PTEN—breast cancer	2.04e-06	1.74e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—breast cancer	2.03e-06	1.73e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—breast cancer	2.03e-06	1.73e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK8—breast cancer	2.03e-06	1.73e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—breast cancer	2.03e-06	1.73e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—HRAS—breast cancer	2.02e-06	1.72e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AKT1—breast cancer	2.02e-06	1.72e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.02e-06	1.72e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.02e-06	1.72e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—STAT3—breast cancer	2.01e-06	1.71e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.01e-06	1.71e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK3—breast cancer	2.01e-06	1.71e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2e-06	1.71e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PTEN—breast cancer	2e-06	1.7e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK8—breast cancer	2e-06	1.7e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2e-06	1.7e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—HRAS—breast cancer	1.99e-06	1.7e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.99e-06	1.7e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.99e-06	1.69e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—breast cancer	1.99e-06	1.69e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ABCB1—breast cancer	1.98e-06	1.69e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—breast cancer	1.98e-06	1.69e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.98e-06	1.68e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL2—breast cancer	1.97e-06	1.68e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.96e-06	1.67e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—breast cancer	1.96e-06	1.67e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.96e-06	1.67e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.96e-06	1.67e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—breast cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TYMS—breast cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.94e-06	1.65e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—breast cancer	1.94e-06	1.65e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PIK3CA—breast cancer	1.93e-06	1.64e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTM1—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NCOR1—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SRC—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CD—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EGFR—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—JUN—breast cancer	1.92e-06	1.64e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.91e-06	1.63e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.91e-06	1.63e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EGFR—breast cancer	1.91e-06	1.63e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—breast cancer	1.91e-06	1.62e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.91e-06	1.62e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—HRAS—breast cancer	1.9e-06	1.62e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—breast cancer	1.9e-06	1.62e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—breast cancer	1.9e-06	1.62e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.9e-06	1.61e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SRC—breast cancer	1.89e-06	1.61e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.88e-06	1.6e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—breast cancer	1.88e-06	1.6e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—breast cancer	1.87e-06	1.6e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—breast cancer	1.87e-06	1.59e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.87e-06	1.59e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.87e-06	1.59e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.86e-06	1.59e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.86e-06	1.58e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.86e-06	1.58e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—STAT3—breast cancer	1.86e-06	1.58e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SRC—breast cancer	1.85e-06	1.58e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—breast cancer	1.85e-06	1.58e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—breast cancer	1.85e-06	1.58e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.84e-06	1.57e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GPX1—breast cancer	1.84e-06	1.57e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.83e-06	1.56e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT1—breast cancer	1.83e-06	1.55e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—STAT3—breast cancer	1.83e-06	1.55e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.82e-06	1.55e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—breast cancer	1.82e-06	1.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.82e-06	1.55e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NOS3—breast cancer	1.81e-06	1.55e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—KRAS—breast cancer	1.81e-06	1.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.81e-06	1.54e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ERCC2—breast cancer	1.81e-06	1.54e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.81e-06	1.54e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—KRAS—breast cancer	1.81e-06	1.54e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—HRAS—breast cancer	1.79e-06	1.53e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT1—breast cancer	1.79e-06	1.52e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.79e-06	1.52e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK3—breast cancer	1.77e-06	1.51e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—HRAS—breast cancer	1.77e-06	1.51e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—HRAS—breast cancer	1.77e-06	1.51e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT1—breast cancer	1.76e-06	1.5e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.76e-06	1.5e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.74e-06	1.49e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.73e-06	1.47e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.73e-06	1.47e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—breast cancer	1.72e-06	1.47e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SRC—breast cancer	1.72e-06	1.47e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—breast cancer	1.72e-06	1.46e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—breast cancer	1.72e-06	1.46e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.71e-06	1.45e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTHFR—breast cancer	1.7e-06	1.45e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—breast cancer	1.7e-06	1.44e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—breast cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—breast cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EGFR—breast cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT1—breast cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CB—breast cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—breast cancer	1.67e-06	1.42e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.67e-06	1.42e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—breast cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—breast cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EGFR—breast cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—breast cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—breast cancer	1.6e-06	1.37e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.6e-06	1.36e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—KRAS—breast cancer	1.59e-06	1.36e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT1—breast cancer	1.58e-06	1.35e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AKT1—breast cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAV1—breast cancer	1.57e-06	1.34e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—KRAS—breast cancer	1.57e-06	1.33e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3CA—breast cancer	1.57e-06	1.33e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT1—breast cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT1—breast cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—breast cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—breast cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—HRAS—breast cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—breast cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—HRAS—breast cancer	1.53e-06	1.31e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—breast cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.51e-06	1.29e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.49e-06	1.27e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—breast cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—breast cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTEN—breast cancer	1.45e-06	1.23e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.44e-06	1.23e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.43e-06	1.22e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—breast cancer	1.43e-06	1.22e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.43e-06	1.21e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—breast cancer	1.42e-06	1.21e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.41e-06	1.2e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.41e-06	1.2e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—breast cancer	1.41e-06	1.2e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—breast cancer	1.39e-06	1.19e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT1—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT1—breast cancer	1.36e-06	1.15e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—HRAS—breast cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—HRAS—breast cancer	1.33e-06	1.13e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT1—breast cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.31e-06	1.12e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.3e-06	1.1e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—breast cancer	1.3e-06	1.1e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AKT1—breast cancer	1.28e-06	1.09e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—breast cancer	1.28e-06	1.09e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—breast cancer	1.27e-06	1.08e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.26e-06	1.07e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—breast cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—breast cancer	1.24e-06	1.06e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.21e-06	1.03e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT1—breast cancer	1.2e-06	1.02e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NOS3—breast cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT1—breast cancer	1.18e-06	1e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—breast cancer	1.16e-06	9.88e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.15e-06	9.81e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.1e-06	9.32e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—breast cancer	1.09e-06	9.24e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.07e-06	9.11e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CA—breast cancer	1.02e-06	8.69e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTEN—breast cancer	9.46e-07	8.06e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKT1—breast cancer	8.34e-07	7.1e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CA—breast cancer	6.68e-07	5.68e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKT1—breast cancer	5.45e-07	4.64e-06	CbGpPWpGaD
